Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prantar Chakrabarti

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
PLOS Digital Health|February 22, 2023
Diseasomics: Actionable machine interpretable disease knowledge at the point-of-careAsoke K Talukder, Lynn Schriml, Arnab Ghosh, et al.
Hemoglobin|October 23, 2013
Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from Eastern IndiaVinaykumar V Bohara, Sudeshna Ray, Prantar Chakrabarti, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Incidence of BCR-ABL transcript variants in patients with chronic myeloid leukemia: Their correlation with presenting features, risk scores and response to treatment with imatinib mesylatePratik Deb, Prantar Chakrabarti, Shila Chakrabarty, et al.
Cell Biology and Toxicology|October 20, 2017
Membrane perturbation through novel cell-penetrating peptides influences intracellular accumulation of imatinib mesylate in CML cellsDevdeep Mukherjee, Niloy Kundu, Lopamudra Chakravarty, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2018
Outbreak of Burkholderia Cepacia Infection: a Systematic Study in a Hematolooncology Unit of a Tertiary Care Hospital from Eastern IndiaShuvra Neel Baul, Rajib De, Prakas Kumar Mandal, et al.
Indian Journal of Pediatrics|February 13, 2020
Is Low Dose a New Dose to Initiate Hemophilia A Prophylaxis? - A Systematic Study in Eastern IndiaShazia Gulshan, Prakas Kumar Mandal, Abhijit Phukan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Response to Immunosuppressive Therapy in Acquired Aplastic Anaemia: Experience of a Tertiary Care Centre from Eastern IndiaBijita Dutta, Tuphan Kanti Dolai, Prakas Kumar Mandal, et al.
Pediatric Hematology and Oncology|June 24, 2008
Actinomycetes species infection in a patient of T-cell acute lymphoblastic leukemia (ALL) presenting with loculated pleural effusionTuphan Kanti Dolai, Rajat Kumar, Prantar Chakrabarti, et al.
Frontiers in Oncology|May 16, 2025
Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensusTulika Seth, Sameer Melinkeri, Tuphan Kanti Dolai, et al.
Blood Cells, Molecules & Diseases|February 20, 2021
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of IndiaManisha Jain, Prantar Chakrabarti, Tuphan Kanti Dolai, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
PLOS Digital Health|February 22, 2023
Diseasomics: Actionable machine interpretable disease knowledge at the point-of-careAsoke K Talukder, Lynn Schriml, Arnab Ghosh, et al.
Hemoglobin|October 23, 2013
Optimizing the dose of hydroxyurea therapy for patients with β-thalassemia intermedia (Hb E-β-thalassemia): a single center study from Eastern IndiaVinaykumar V Bohara, Sudeshna Ray, Prantar Chakrabarti, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Incidence of BCR-ABL transcript variants in patients with chronic myeloid leukemia: Their correlation with presenting features, risk scores and response to treatment with imatinib mesylatePratik Deb, Prantar Chakrabarti, Shila Chakrabarty, et al.
Cell Biology and Toxicology|October 20, 2017
Membrane perturbation through novel cell-penetrating peptides influences intracellular accumulation of imatinib mesylate in CML cellsDevdeep Mukherjee, Niloy Kundu, Lopamudra Chakravarty, et al.
Mediterranean Journal of Hematology and Infectious Diseases|September 14, 2018
Outbreak of Burkholderia Cepacia Infection: a Systematic Study in a Hematolooncology Unit of a Tertiary Care Hospital from Eastern IndiaShuvra Neel Baul, Rajib De, Prakas Kumar Mandal, et al.
Indian Journal of Pediatrics|February 13, 2020
Is Low Dose a New Dose to Initiate Hemophilia A Prophylaxis? - A Systematic Study in Eastern IndiaShazia Gulshan, Prakas Kumar Mandal, Abhijit Phukan, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Response to Immunosuppressive Therapy in Acquired Aplastic Anaemia: Experience of a Tertiary Care Centre from Eastern IndiaBijita Dutta, Tuphan Kanti Dolai, Prakas Kumar Mandal, et al.
Pediatric Hematology and Oncology|June 24, 2008
Actinomycetes species infection in a patient of T-cell acute lymphoblastic leukemia (ALL) presenting with loculated pleural effusionTuphan Kanti Dolai, Rajat Kumar, Prantar Chakrabarti, et al.
Frontiers in Oncology|May 16, 2025
Preventing pneumococcal infections in patients with hematological malignancies: a review of evidence and recommendations based on modified Delphi consensusTulika Seth, Sameer Melinkeri, Tuphan Kanti Dolai, et al.
Blood Cells, Molecules & Diseases|February 20, 2021
Comparison of efficacy and safety of thalidomide vs hydroxyurea in patients with Hb E-β thalassemia - a pilot study from a tertiary care Centre of IndiaManisha Jain, Prantar Chakrabarti, Tuphan Kanti Dolai, et al.
Pageof 5